SOPHiA GENETICS SA (SOPH) Q1 2025 Earnings
SOPH·Reported May 6, 2025·Before market open
SOPHiA GENETICS SA reported Q1 2025 revenue of $17.8M (+12.7% YoY), beat analyst consensus of $17.4M by $337.8K. Diluted EPS came in at $-0.26 (-23.8% YoY), missed the $-0.21 consensus by $0.05.
Revenue
$17.8Mbeat by $337.8K
Consensus: $17.4MDiluted EPS
$-0.26missed by $0.05
Consensus: $-0.21
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q1 2025 Earnings FAQ
Common questions about SOPHiA GENETICS SA's Q1 2025 earnings report.
SOPHiA GENETICS SA (SOPH) reported Q1 2025 earnings on May 6, 2025 before market open.
SOPHiA GENETICS SA reported revenue of $17.8M and diluted EPS of $-0.26 for Q1 2025.
Revenue beat the consensus estimate of $17.4M by $337.8K. EPS missed the consensus estimate of $-0.21 by $0.05.
Compared to the same quarter a year prior, revenue grew 12.7% from $15.8M a year earlier and diluted EPS declined 23.8% from $-0.21.